Pain, PSA flare, and bone scan response in a patient with metastatic castration-resistant prostate cancer treated with radium-223, a case report

BACKGROUND: Radium-223 has been shown to improve overall survival in men with metastatic castration-resistant prostate cancer with symptomatic bone metastases. The bone scan response to radium-223 has only been described in one single center trial of 14 patients, none of whom achieved the outstandin...

Descripción completa

Detalles Bibliográficos
Autores principales: McNamara, Megan A, George, Daniel J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426169/
https://www.ncbi.nlm.nih.gov/pubmed/25948240
http://dx.doi.org/10.1186/s12885-015-1390-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426169/
https://www.ncbi.nlm.nih.gov/pubmed/25948240
http://dx.doi.org/10.1186/s12885-015-1390-y

Ejemplares similares